Nova Leap HealthNVLPF 50 Cash Ratio is 0.44 as of Mar. 2026, which is 10% above its 10-year median of 0.40. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.22 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 663 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 58.82% on this metric.
Nova Leap Health has a Cash Ratio of 0.44. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Nova Leap Health's Cash Ratio or its related term are showing as below:
NVLPF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.13 Med: 0.4 Max: 6.77
Current: 0.44
During the past 10 years, Nova Leap Health's highest Cash Ratio was 6.77. The lowest was 0.13. And the median was 0.40.
NVLPF's Cash Ratio is ranked worse than 58.82% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 0.61
vs NVLPF: 0.44
Nova Leap Health (OTCPK:NVLPF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Nova Leap Health Cash Ratio Related Terms
Nova Leap Health Cash Ratio Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Leap Health (NVLPF) has a Cash Ratio of 0.44 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Nova Leap Health and its competitors. This is 10% above median its historical median of 0.40. Over the past decade, Nova Leap Health's Cash Ratio has ranged from 0.13 to 6.77. According to the industry distribution chart, Nova Leap Health ranks #390 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 58.8%.
Is Nova Leap Health's Cash Ratio too high?
Nova Leap Health's current Cash Ratio of 0.44 is 10% above median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 6.77. The Healthcare Providers & Services industry median Cash Ratio is 0.61. Nova Leap Health's value of 0.44 is 27.9% below this industry median. Based on the distribution chart, Nova Leap Health ranks #390 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Cash Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #390 out of 663 companies for Cash Ratio. This places Nova Leap Health in the lower half of its industry. The industry median Cash Ratio is 0.61. Nova Leap Health's value of 0.44 is 27.9% below this benchmark. Historically, Nova Leap Health's own Cash Ratio has ranged from 0.13 to 6.77 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.61, Nova Leap Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.61, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Cash Ratio of 0.44 is 27.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Cash Ratio is 0.44, which is 10% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.22, compared to a current price of $0.26 — trading 18.2% above its estimated fair value. The current Cash Ratio is 0.44, which is 10% above median its 10-year median of 0.40 and 27.9% below the Healthcare Providers & Services industry median of 0.61. Nova Leap Health's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Cash Ratio is 0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.26 is trading 18.2% above its estimated GF Value™ of $0.22.
GuruFocus considers Nova Leap Health to be Modestly Overvalued.
Key valuation signals for NVLPF:
Cash Ratio: 0.44 (10% above median its 10-year median of 0.40)
GF Value™: $0.22 vs. price of $0.26 (18.2% above fair value)
Industry Position: 27.9% below the Healthcare Providers & Services median (#390 of 663)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
